Read more on the Slice of MIT blog about Nina Tandon SM '06 and her work at EpiBone: http://bit.ly/2l6kDix
Bone-related surgeries can fail due to unsuccessful integration of prosthetic or donor bone implants. Nina Tandon SM ’06 is working to solve this problem by growing human bone from the cells of the patient.
Tandon, CEO of EpiBone, leads the New York City-based company that is delivering custom-made bones. The bones are more likely to integrate into the body not only because they are living, compatible tissue, but because they are created based on a CT scan of the target area and are made to fit exactly.
"The long-term vision for our field is to banish organ donation," says Tandon
"To be able to say, let's start with the living building blocks of life...and collaborate with them to generate replacement parts for the human body."
#massachusettsinstituteoftechnology #stemcells #bioengineering